Jennifer Lynn Minai-Azary, CFO of Context Therapeutics Inc. ($CNTX), made one open market purchase of shares worth $25,486 in the last 365 days. Her most recent buy occurred on June 6, 2025. This ranks her 3,572nd among 4,983 insiders by purchase value, well below the average of $1.46 million across about 3.3 transactions. She reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Context Therapeutics Inc. | $CNTX | Minai-Azary Jennifer Lynn | Chief Financial Officer | A | Stock Option (right to buy) | 275000 | $0.00 | 275,000.0000 | 95,186,346 | 9999.99% | 0.29% |
| June 6, 2025 | Context Therapeutics Inc. | $CNTX | Minai-Azary Jennifer Lynn | Chief Financial Officer | P | Common Stock | 40010 | $0.64 | 80,010.0000 | 58,416,141 | 100.03% | 0.07% |
| Feb. 13, 2025 | Context Therapeutics Inc. | $CNTX | Minai-Azary Jennifer Lynn | Chief Financial Officer | A | Stock Option (right to buy) | 371800 | $0.00 | 371,800.0000 | 58,416,141 | 9999.99% | 0.64% |
| March 21, 2024 | Context Therapeutics Inc. | $CNTX | Minai-Azary Jennifer Lynn | Chief Financial Officer | A | Stock Option (right to buy) | 160115 | $0.00 | 160,115.0000 | 15,966,053 | 9999.99% | 1.00% |
| Feb. 13, 2023 | Context Therapeutics Inc. | $CNTX | Minai-Azary Jennifer Lynn | Chief Financial Officer | A | Stock Option (right to buy) | 158001 | $0.00 | 158,001.0000 | 0 | 9999.99% | 0.00% |